Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth (Q40650358)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2003

Language	Label	Description	Also known as
English	Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth	scientific article published on May 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

0 references

author name string

Phong Trang

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kihoon Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Jiaming Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Fenyong Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Journal of Molecular Biology

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

328

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1123-1135

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Intracellular applications of ribozymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Conservation of a hairpin ribozyme sequence in HIV-1 is required for efficient viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Group II introns designed to insert into therapeutically relevant DNA target sites in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Ribozymes as potential anti-HIV-1 therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Ribozymes, genomics and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Ribonuclease P: unity and diversity in a tRNA processing ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

External Guide Sequences for an RNA Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Rational design of self-cleaving pre-tRNA-ribonuclease P RNA conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

UV cross-link mapping of the substrate-binding site of an RNase P ribozyme to a target mRNA sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Lethal and temperature-sensitive mutations and their suppressors identify an essential structural element in U2 small nuclear RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Requirements for cleavage by a modified RNase P of a small model substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Targeted cleavage of mRNA by human RNase P

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Inhibition of viral gene expression by human ribonuclease P.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Expression of small, therapeutic RNAs in human cell nuclei.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Escherichia coli proteins, including ribosomal protein S12, facilitate in vitro splicing of phage T4 introns by acting as RNA chaperones

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Protein Enhancement of Hammerhead Ribozyme Catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Kinetics of intermolecular cleavage by hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Direct measurement of oligonucleotide substrate binding to wild-type and mutant ribozymes from Tetrahymena

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Evolutionary variation in bacterial RNase P RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Further perspective on the catalytic core and secondary structure of ribonuclease P RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotype of the herpes simplex virus type 1 protease substrate ICP35 mutant virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-2836(03)00398-X

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40650358&oldid=1904133895"